LifeSprout, Inc.

LifeSprout, Inc.

Revolutionary Products for Soft Tissue Replacement and Regeneration

Founded 2015

Baltimore, United States 16 employees Series A Total: $35.80M Biotechnology, Health Care

LifeSprout, Inc., founded in 2015, is at the forefront of innovation within the Biotechnology and Health Care sectors. Headquartered in the United States, the company is revolutionizing the field of aesthetic and regenerative medicine with its slogan, "Revolutionary Products for Soft Tissue Replacement and Regeneration."

LifeSprout leverages breakthroughs in materials science to develop products that mimic the body’s own tissues, addressing the needs of patients experiencing soft tissue losses due to aging, cancer, and metabolic diseases. Their advanced solutions aim to enhance both form and function, offering minimal downtime and exceptional results.

In its significant milestone, LifeSprout secured a $28.50M Series A investment on April 27, 2020. This round was backed by reputable investors, including Camden Partners, Redmile Group, Emerald Development Managers, Nexus Capital Management, Triskelion Capital, and the Abell Foundation. This substantial investment underscores investor confidence in LifeSprout’s innovative approach and potential for future growth.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	$28.50M	3	Redmile Group, Emerald Development Managers +1	01 Apr 2020
Early VC	$6.50M	4	angelMD, TEDCO +2	01 Jun 2018
Seed	$500.00K	2	TEDCO, Abell Foundation	01 Mar 2018
Grant	$300.00K	1	Maryland Stem Cell Research Fund (MSCRF)	01 Sep 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

$28.50M

Redmile Group, Emerald Development Managers +1

01 Apr 2020

Early VC

$6.50M

angelMD, TEDCO +2

01 Jun 2018

Seed

$500.00K

TEDCO, Abell Foundation

01 Mar 2018

Grant

$300.00K

Maryland Stem Cell Research Fund (MSCRF)

01 Sep 2017

FAQ About LifeSprout, Inc.

Revolutionary Products for Soft Tissue Replacement and Regeneration

LifeSprout, Inc. was founded in 2015.

LifeSprout, Inc. is headquartered in Baltimore, United States.

LifeSprout, Inc. operates in Biotechnology and Health Care. Its work centres on Regenerative Medicine, Aesthetic Medicine, Soft Tissue Replacement and Materials Science. Its customers include Patients with soft tissue losses, Individuals affected by aging, cancer, and metabolic diseases and Healthcare providers specializing in tissue restoration.

LifeSprout, Inc. has approximately 16 employees.

LifeSprout, Inc. has completed 4 funding rounds, raising a total of $35.80M. The latest funding stage is Series A.

LifeSprout, Inc. offers: Development of products for aesthetic medicine, Solutions for regenerative medicine, Soft tissue restoration products.

Top alternatives and competitors to LifeSprout, Inc. include BioViva USA Inc., Aptus Bioreactors, Harvard Apparatus Regenerative Technology, Inc., 4D Biomaterials, osteobionix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

LifeSprout, Inc. and BioViva USA Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About LifeSprout, Inc.

Services & Products

Target Customers

Funding Rounds & Investors (4)

LifeSprout, Inc. Alternatives & Competitors

FAQ About LifeSprout, Inc.